{
  "docId": "019de074-704c-735b-b7a3-613838aa1bf3",
  "docSlug": "9b81d8a09c69afc3f139dc970effabde",
  "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 39 slides",
  "authorId": "aeglea-biotherapeutics",
  "authorName": "Aeglea BioTherapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 37,
  "pageCount": 39,
  "prevPage": 36,
  "nextPage": 38,
  "slideType": "appendix_methodology",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "The slide uses a process flow diagram to illustrate the clinical trial structure.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-704c-735b-b7a3-613838aa1bf3/37",
  "deckHref": "/decks/019de074-704c-735b-b7a3-613838aa1bf3",
  "deckJsonHref": "/decks/019de074-704c-735b-b7a3-613838aa1bf3.json",
  "deckAnchorHref": "/decks/019de074-704c-735b-b7a3-613838aa1bf3#slide-37",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.893,
        "x": 0.106,
        "y": 0.285
      },
      "kind": "diagram",
      "text": "Clinical trial flow from patient selection to randomization, treatment arms, and long-term extension.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a44fd3bd-1f59-4def-88d4-fd683ba49892",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.74,
        "x": 0.062,
        "y": 0.868
      },
      "kind": "source-note",
      "text": "*Dosing is weekly and, if needed, dose is modified based on plasma arginine levels with maintenance of blinding. ‡The first 8 weeks of the open-label extension will be blinded. All study participants remain on current disease management for the duration of the trial.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8d9d3766-b164-4682-8984-c1a7eb99ed85",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.932,
        "x": 0.068,
        "y": 0.608
      },
      "kind": "table",
      "text": "Key Endpoints and Analysis details",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5b6e4e26-0c15-4009-a367-3493f11f45ad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.034,
        "w": 0.851,
        "x": 0.068,
        "y": 0.198
      },
      "kind": "title",
      "text": "Double-blind portion of trial complete – topline data announced December 2021",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7bf00051-deb5-4f49-a980-a2c439419e0a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.044,
        "w": 0.391,
        "x": 0.068,
        "y": 0.048
      },
      "kind": "title",
      "text": "PEACE Phase 3 Study Design",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e285731a-3bff-481e-9896-ad67bec6e415",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "clinical-trial-design",
      "slug": null,
      "matchId": "f195fa67-b50a-45e9-9922-df4024ae9e7e",
      "evidence": "Standardized representation of patient cohorts, randomization, and endpoints.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}